Indo US Bio-Tech Limited
Indo US Bio-Tech Limited (INDOUS.BO) Stock Overview
Explore Indo US Bio-Tech Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.7B
P/E Ratio
18.46
EPS (TTM)
$7.40
ROE
0.19%
INDOUS.BO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Indo US Bio-Tech Limited (INDOUS.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 52.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $264.29.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.46 and a market capitalization of 2.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.